Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $195.2 million.

  • Pediatrix Medical's Free Cash Flow rose 4060.89% to $132.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $278.3 million, marking a year-over-year increase of 11774.73%. This contributed to the annual value of $195.2 million for FY2024, which is 7314.66% up from last year.
  • Per Pediatrix Medical's latest filing, its Free Cash Flow stood at $195.2 million for FY2024, which was up 7314.66% from $112.8 million recorded in FY2023.
  • Pediatrix Medical's 5-year Free Cash Flow high stood at $195.2 million for FY2024, and its period low was $81.5 million during FY2021.
  • Over the past 5 years, Pediatrix Medical's median Free Cash Flow value was $152.6 million (recorded in 2022), while the average stood at $143.6 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 5364.27% in 2021, then surged by 8721.89% in 2022.
  • Over the past 5 years, Pediatrix Medical's Free Cash Flow (Annual) stood at $175.8 million in 2020, then plummeted by 53.64% to $81.5 million in 2021, then skyrocketed by 87.22% to $152.6 million in 2022, then decreased by 26.11% to $112.8 million in 2023, then skyrocketed by 73.15% to $195.2 million in 2024.
  • Its Free Cash Flow stands at $195.2 million for FY2024, versus $112.8 million for FY2023 and $152.6 million for FY2022.